Higher circulating vitamin D levels in early midlife are associated with lower tau deposition on brain imaging approximately 16 years later in dementia-free adults, based on a study of 435 participants from the Framingham Heart Study. No significant relationship was found between vitamin D levels and amyloid burden.
Background
The relationship between vitamin D levels and neurodegenerative processes, particularly in Alzheimer's disease, is of increasing interest. Understanding modifiable factors like vitamin D could provide insights into preventing or delaying dementia onset, as supported by various studies.
Data Highlights
Measure
Findings
Mean serum 25-hydroxyvitamin D
38 ng/mL (significant for brain health)
Participants with levels below 30 ng/mL
34%
Participants taking vitamin D supplements
5%
Key Findings
Higher vitamin D levels were linked to lower global tau burden (statistically significant).
Lower tau burden was observed in brain regions vulnerable to early Alzheimer disease.
No association was found between vitamin D levels and amyloid burden.
Findings remained consistent even after excluding participants taking vitamin D supplements.
The study population was predominantly White and relatively young, limiting generalizability.
Clinical Implications
Clinicians should consider the potential role of vitamin D in brain health, particularly in midlife patients. While higher vitamin D levels may be associated with lower tau deposition, further research, including clinical trials, is needed to establish causation and clinical recommendations.
Conclusion
This study suggests that higher serum vitamin D levels in early midlife may be associated with lower tau deposition in later life, highlighting the need for further investigation into vitamin D as a modifiable risk factor for dementia, while acknowledging the study's limitations.
Older patients with documented cognitive impairment also experienced greater postoperative functional decline following elective total knee arthroplasty
This week's research makes one thing clear: who someone is before they get sick — their relationships, their partner's health, the back of their eye — is doing a lot of work medicine is only beginning to account for.
A new BMJ Opinion piece takes aim at a growing tendency among clinicians: translating public behavior into clinical diagnosis—especially when the subject is a political leader.
